Similar antiproliferative effects were also detected in patient‐derived GBM cell lines obtained from the “Human Glioblastoma Cell Culture” (HGCC) biobank,[23] where knockdown of PANK4 followed by TMZ treatment led to an improved response to the drug (Figure 2E). This evidence concerns the gene PANK4 and glioblastoma.